Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andersen

Showing results (331-340 of 530) with videos related to

Pageof 53
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 6, 2019
Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administrationSigne Tandrup Schmidt, Camilla Line Olsen, Henrik Franzyk, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
BMC Veterinary Research|September 12, 2016
Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar DKarin Erneholm, Emma Lorenzen, Sarah Bøje, et al.
Plos One|December 19, 2013
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccinationTruc Hoang, Claus Aagaard, Jes Dietrich, et al.
Ebiomedicine|May 14, 2024
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccinationIda Rosenkrands, Anja W Olsen, Sara Knudsen, et al.
Plos One|February 2, 2011
Validation of the ALS assay in adult patients with culture confirmed pulmonary tuberculosisRokeya Sultana Rekha, S M Mostafa Kamal, Peter Andersen, et al.
Journal of Immunological Methods|June 7, 2011
Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infectionEmilie Borgström, Peter Andersen, Lena Andersson, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 testPernille Ravn, Martin E Munk, Ase Bengaard Andersen, et al.
The EMBO Journal|November 26, 2013
SERCA mutant E309Q binds two Ca(2+) ions but adopts a catalytically incompetent conformationJohannes D Clausen, Maike Bublitz, Bertrand Arnou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnosticsNiels Peter H Knudsen, Sara Nørskov-Lauritsen, Gregory M Dolganov, et al.
Pageof 53

Showing results (331-340 of 530) with videos related to

Sort By:
Pageof 53
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 6, 2019
Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administrationSigne Tandrup Schmidt, Camilla Line Olsen, Henrik Franzyk, et al.
Plos One|August 16, 2016
Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of TuberculosisRolf Billeskov, Esterlina V Tan, Marjorie Cang, et al.
BMC Veterinary Research|September 12, 2016
Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar DKarin Erneholm, Emma Lorenzen, Sarah Bøje, et al.
Plos One|December 19, 2013
ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccinationTruc Hoang, Claus Aagaard, Jes Dietrich, et al.
Ebiomedicine|May 14, 2024
Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccinationIda Rosenkrands, Anja W Olsen, Sara Knudsen, et al.
Plos One|February 2, 2011
Validation of the ALS assay in adult patients with culture confirmed pulmonary tuberculosisRokeya Sultana Rekha, S M Mostafa Kamal, Peter Andersen, et al.
Journal of Immunological Methods|June 7, 2011
Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infectionEmilie Borgström, Peter Andersen, Lena Andersson, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 testPernille Ravn, Martin E Munk, Ase Bengaard Andersen, et al.
The EMBO Journal|November 26, 2013
SERCA mutant E309Q binds two Ca(2+) ions but adopts a catalytically incompetent conformationJohannes D Clausen, Maike Bublitz, Bertrand Arnou, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2014
Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnosticsNiels Peter H Knudsen, Sara Nørskov-Lauritsen, Gregory M Dolganov, et al.
Pageof 53